Since late 2019, people all over the world have heard of COVID-19, or coronavirus. Since then, it has been a part of our lives, dominating the news and resulting in a growing number of infections and deaths worldwide.

Meanwhile, we know more about the virus, its ways of spreading, and the symptoms it causes. In this context we also learned about a new development: Long COVID. People who have had COVID-19, and are on the mend, start to experience similar symptoms once again, while their test results are negative, and their platelet counts are normal.

To learn more about Long COVID, we turned to the Long Covid Alliance, a network of patient advocates, scientists, disease experts, and drug developers. They have joined their collective knowledge and resources in order to educate policy makers and accelerate research to transform the understanding of post-viral illness. We spoke with Emily Taylor, Vice President of Advocacy and Engagement at Solve M.E., co-founder of the Long Covid Alliance.

Note: The statements and opinions contained in the video and the podcast episode are solely those of the speaker.

Video Interview

Podcast Interview

To access further The Waiting Room Podcast episodes and/or subscribe to the podcast channel, visit The Waiting Room Podcast landing page.

Related Posts

Peritoneal dialysis (PD) enables people with kidney failure to conduct dialysis at home by themselves. During the COVID-19 pandemic, increased...
Inspired by the recent report “Vaccine Toes Are the New COVID Toes” published in the journal Skin Appendage Disorders, this...
We’re all accustomed to wearing masks in public now due to the COVID-19 pandemic. However, there are some issues that...